The tolerability of lamotrigine in elderly patients with epilepsy

Drugs and Aging

Volumn 18, Issue 8, 2001, Pages 621-630

  Giorgi, L ^a   Gomez, G ^b   O'Neill, F ^a   Hammer, A E ^b   Risner, M ^b  

^a GLAXOSMITHKLINE   (United Kingdom)

^b GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CLONAZEPAM; GABAPENTIN; LAMOTRIGINE; LORAZEPAM; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; VALPROIC ACID;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG INDUCED DISEASE; DRUG TOLERABILITY; DRUG WITHDRAWAL; ELDERLY CARE; EPILEPSY; EXPOSURE; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PRESCRIPTION; PRIORITY JOURNAL; RASH; SOMNOLENCE;

EID: 0034867270     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-200118080-00006     Document Type: Article

References (24)

1. Seizure disorders: The changes with age
2. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984
3. Etiology of seizures in the elderly
4. Risk factors for adult-onset first seizures
5. Antiepileptic drug therapy in the elderly
6. Neuropharmacology in the elderly
7. Drug disposition in old age
8. Management of epilepsy in the elderly
9. Dose-related adverse effects of anticonvulsants
10. An evaluation of antiepileptic drug therapy in nursing facilities
11. Newer antiepileptic drugs: Gabapentin, lamotrigine, felbamate, topiramate and fosphenytoin
12. Lamotrigine: A review of its pharmacological properties and clinical efficacy in epilepsy
13. Lamotrigine: Mechanisms of action
14. Double-blind, placebo-controlled crossover study of lamotrigine in treatment-resistant partial seizures
15. Comparison of lamotrigine (Lamictal) and phenytoin monotherapy in newly-diagnosed epilepsy
16. Double-blind cross-over trial of lamotrigine (Lamictal) as add-on therapy in intractable epilepsy
17. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy
18. Safety review of adult clinical trial experience with lamotrigine
19. Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy
20. Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy
21. Cognitive adverse events of antiepileptic drugs: Incidence, mechanisms and therapeutic implications
22. Cognitive side-effects of chronic antiepileptic drug treatment
23. An active-control trial of lamotrigine monotherapy for partial seizures
24. Comparison of lamotrigine pharmacokinetics in young and elderly volunteers